Ambrx Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: AMAM only recently listed within the past 12 months.

Top 25 shareholders own 100.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.3%	Darwin Global Management Limited	16,688,636	US$466.9m	-85.7%	72.32%
17.7%	Cormorant Asset Management, LP	11,231,000	US$314.2m	-83.8%	12.97%
6.87%	Paradigm Biocapital Advisors LP	4,352,689	US$121.8m	-82.2%	5.04%
6.69%	D. E. Shaw & Co., L.P.	4,240,488	US$118.6m	-84.9%	0.01%
5.86%	Deep Track Capital, LP	3,710,412	US$103.8m	0%	3.17%
4.94%	Nextech Invest Ltd.	3,129,300	US$87.6m	0%	12.68%
3.4%	Balyasny Asset Management L.P.	2,154,700	US$60.3m	0%	0.16%
3.31%	Logos Global Management, L.P.	2,100,000	US$58.8m	161%	5.5%
3.27%	VR Adviser, LLC	2,070,000	US$57.9m	-85.7%	2.59%
3.22%	Citadel Advisors LLC	2,042,212	US$57.1m	-62%	0.06%
2.33%	FMR LLC	1,474,258	US$41.2m	-88%	no data
2.21%	The Vanguard Group, Inc.	1,399,642	US$39.2m	0%	no data
1.98%	Woodline Partners LP	1,255,148	US$35.1m	0%	0.36%
1.71%	T. Rowe Price Group, Inc.	1,084,247	US$30.3m	-81.2%	no data
1.67%	Hopu Reunion Co Ltd	1,060,000	US$29.7m	0%	no data
1.58%	WuXi PharmaTech Healthcare Fund I General Partner L.P.	1,000,000	US$28.0m	0%	63.82%
1.58%	WuXi AppTec Co., Ltd., Investment Arm	1,000,000	US$28.0m	0%	44.62%
1.32%	HBM Partners Ltd.	833,443	US$23.3m	-90.1%	2.34%
0.79%	BlackRock, Inc.	501,604	US$14.0m	0%	no data
0.77%	Holocene Advisors, LP	486,562	US$13.6m	-85.7%	0.05%
0.75%	Ghost Tree Capital, LLC	475,000	US$13.3m	-87.1%	6.62%
0.68%	Millennium Management LLC	432,709	US$12.1m	-86.7%	0.01%
0.63%	Goldman Sachs & Co. LLC	399,648	US$11.2m	0%	no data
0.61%	Ally Bridge Group	385,383	US$10.8m	-80.4%	3.1%
0.52%	Federated Hermes, Inc.	330,949	US$9.3m	-98%	0.02%